Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-19-025493
Filing Date
2019-10-10
Accepted
2019-10-10 21:44:14
Documents
1
Period of Report
2019-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4274
  Complete submission text file 0000899243-19-025493.txt   5876
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Mulholland Michael D. (Reporting) CIK: 0001257911 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-49908 | Film No.: 191146964